Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OASM

Oasmia Pharmaceutical AB (publ) (OASM) Stock Price, News & Analysis

About Oasmia Pharmaceutical AB (publ) Stock (NASDAQ:OASM)

Advanced Chart

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$1.30
$1.62
52-Week Range
$0.94
$5.70
Volume
N/A
Average Volume
98,414 shs
Market Capitalization
$1.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Receive OASM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oasmia Pharmaceutical AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

OASM Stock News Headlines

Sector-Health Care & Pharmaceuticals
Warning: Prepare to Be Shocked by These Payouts
There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.
BOEUF Bonesupport Holding AB (publ)
Lipigon Pharmaceuticals AB LPGO
Resurs Holding AB (publ) (RESURS.ST)
See More Headlines

OASM Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Oasmia Pharmaceutical AB (publ) investors own include Protalix BioTherapeutics (PLX), Amarin (AMRN), Bristol-Myers Squibb (BMY), CRISPR Therapeutics (CRSP), Supernus Pharmaceuticals (SUPN), VBI Vaccines (VBIV) and Verastem (VSTM).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OASM
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-18,950,000.00
Net Margins
-8,633.64%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$220,000.00
Price / Cash Flow
N/A
Book Value
$0.63 per share
Price / Book
0.03

Miscellaneous

Free Float
N/A
Market Cap
$1.50 million
Optionable
Not Optionable
Beta
0.96
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:OASM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners